Australia markets closed

Vivoryon Therapeutics NV (05Y.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
0.82200.0000 (0.00%)
As of 08:15AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
-3,620
-3,620
0
10,764
0
Cost of revenue
-525
-525
0
1,569
0
Gross profit
-3,095
-3,095
0
9,196
0
Operating expenses
Research development
17,637
17,637
20,224
17,452
13,210
Selling general and administrative
3,272
3,272
4,898
2,354
1,523
Total operating expenses
25,700
25,700
29,059
22,094
16,011
Operating income or loss
-28,795
-28,795
-29,059
-12,898
-16,011
Interest expense
56
56
24
24
23
Income before tax
-28,576
-28,576
-28,355
-12,223
-16,510
Income tax expense
-234
-234
-199
432
0
Income from continuing operations
-28,342
-28,342
-28,156
-12,655
-16,510
Net income
-28,342
-28,342
-28,156
-12,655
-16,510
Net income available to common shareholders
-28,342
-28,342
-28,156
-12,655
-16,510
Basic EPS
-1.12
-
-1.28
-0.63
-0.83
Diluted EPS
-1.12
-
-1.28
-0.63
-0.83
Basic average shares
23,711
-
22,020
20,000
19,975
Diluted average shares
23,711
-
22,020
20,000
19,975